@FierceBiotech: Analysis: For Eli Lilly's solanezumab, take 2 doesn't look so pretty. More | Follow @FierceBiotech
@JohnCFierce: FDA wants a rewrite on Lemtrada app? Bit of an embarrassment for Genzyme and its overseers at Sanofi. Report | Follow @JohnCFierce
@RyanMFierce: Ex-Google guys eye clinical trials with startup Flatiron. Story | Follow @RyanMFierce
> The Philadelphia Business Journal has run a slide show on the gleaming new facility that GlaxoSmithKline ($GSK) is building in the Navy Yard. Slideshow
> The European Society of Cardiology meeting, like all scientific sessions, included a considerable amount of news handed out under embargo. Today the group sanctioned theheart.org and sister company Medscape for breaking its embargo on the Effient study, stripping a reporter of her credentials and barring the groups from covering its events for a full year. In a particularly harsh move, anyone who hires the freelancer involved will also be barred. Story
> The EU has granted marketing authorization for Meda's Zyclara, a new drug for actinic keratosis. Story
Pharma News
@FiercePharma: Interested in the new GSK site at Philly's Navy Yard? 22 pics of construction in progress--via Philadelphia Business Journal. Gallery | Follow @FiercePharma
> Roche makes a tax deal on doomed Nutley site. More
> Lilly's Effient hopes dashed by head-to-head Plavix trial. Article
> Hospira adding 200 jobs at NC plant. News
> No more bids for Par Pharma, so $1.9B deal with TPG stands. Report
@FierceMedDev: It's a good day to be CardioDx. The company pulled in $58M in new financing. News | Follow @FierceMedDev
@MarkHFierce: Cook Medical opens a new plant today in Illinois. Article | Follow @MarkHFierce
@DamianFierce: The first wave of renal denervation devices have impressed docs in the EU. Report | Follow @DamianFierce
> Boston Sci gets expanded CE mark for Watchman, awaits FDA nod. Article
> CardioDx pulls in $58M to expand Dx commercial sales. News
> Interleukin Genetics' founder returns to CEO slot. Item
Biotech IT News
> Groups craft algorithms to rank drug contenders. Story
> Sanofi takes wisdom of crowd in social media blitz. Item
> Ex-Google guys eye clinical trials with startup Flatiron. News
> Amazon targets pharma R&D, others with new cloud storage. More
> Boehringer sets launch date for pharma's first social game on Facebook. Article
CRO News
> Chinese CRO Tigermed completes $80M IPO. Item
> West to open CMO facility in India. Story
> Pfizer backs out of generics deal with India's Claris. News
> PRA expands its Chinese presence as market swells. Article
> Researchers bristle at India's proposed trial reforms. Story
And Finally… Women who lack the required amount of sleep could be subjecting themselves to a higher risk of breast cancer. More